Syndax Pharmaceuticals Cash Flow Statement (2015-2026) | SNDX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Dec2024 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-14.21M-15.10M-16.61M-19.85M-19.86M
Depreciation and Depletion (Quarter)
4.00M
Share-based Compensation (Quarter)
12.05M
Gains from Sales and Divestitures (Quarter)
0.01M0.00M0.00M0.04M0.04M0.01M0.01M0.01M0.01M0.09M0.41M
Gains from Investment Securities (Quarter)
0.01M1.12M0.14M0.19M0.00M2.30M2.30M2.50M10.10M0.01M0.01M17.00M0.31M1.10M11.69M3.98M
Non-cash Items (Quarter)
6.31M15.60M81.94M31.70M68.61M0.08M0.21M0.35M88.02M0.08M0.21M0.35M55.09M9.75M7.53M
Cash from Operations (Quarter)
-50.34M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.86M
Amortization of Deferred Charges (Quarter)
0.06M
Depreciation & Amortization (CF) (Quarter)
4.00M
Change in Working Capital
Change in Receivables (Quarter)
-6.14M
Change in Inventory (Quarter)
2.06M
Change in Account Payables (Quarter)
-5.74M
Change in Accured Expenses (Quarter)
-28.35M
Other Working Capital Changes (Quarter)
-7.84M
Investing Activities
Capital Expenditures (Quarter)
0.06M
Change in Acquisitions & Divestments (Quarter)
77.78M
Cash from Investing Activities (Quarter)
38.39M
Financing Activities
Other financing activities (Quarter)
0.06M0.06M0.09M0.09M-0.24M0.08M0.06M0.10M-0.24M0.09M
Cash from Financing Activities (Quarter)
7.92M
Additional items
Change in Cash (Quarter)
-4.04M
Free Cash Flow (Quarter)
-50.34M
Net Cash Flow (Quarter)
-4.04M